Grants Awarded

1. Principal Investigator (PI) – ICMR-Intermediate Research Grant of 7.8 Cr. INR on "Investigating the Diagnostic Potential of Gut-Associated Metabolites in Post-Menopausal Osteoporotic Women and Exploring Their Therapeutic Potential in Pre-Clinical Model of Osteoporosis: An Osteoimmunological Approach”, 2024-2027 (Approved).


2. Principal Investigator (PI) – ICMR-Small Extramural Research Grant of 1.9 Cr. INR on "To establish the therapeutic potential of probiotics and their associated metabolites in mitigating pulmonary and extrapulmonary ARDS under preclinical and clinical conditions”, 2024-2027 (Approved).


3. Co-Principal Investigator (Co-PI) – DBT-Welcome India Alliance TEAM Grant of 9.57 Cr INR on “Identification of key ligand/ligand complexes for Plasmodium falciparum merozoite using Cyro-EM, proteome and immunological approaches - A Step towards the development of an efficacious malaria blood stage vaccine”, 2023-2028.


4. Principal Investigator (PI) – CCRH-AYUSH Grant of 70 Lacs INR on “To investigate the bone protective potential of selected homeopathic formulations (SHFs) in osteoporotic conditions”, 2022-2025.


5. Principal Investigator (PI) – Department of Biotechnology (DBT) Grant of 82 Lacs INR on "To elucidate the immunomodulatory role of probiotics in modulating bone health in post-menopausal osteoporosis via its effect on ILC3-ILCreg cell axis", 2021-2024.


6. Principal Investigator (PI) - Indian Council of Medical Research (ICMR) Grant of 73 Lacs INR on "To investigate the therapeutic potential of probiotics in treatment and management of osteoporosis: “Role of regulatory B cells (Bregs)”, 2023-2026.


7. Principal Investigator (PI) - Science and Engineering Research Board (SERB)-Extra Mural Research Grant of 65 Lacs USD (Department of Science and technology, Govt. of India) on "Elucidation of Cellular mechanisms involving GUT resident regulatory T cells in Probiotics mediated inhibition of Osteoporosis", 2018-2022.


8. Principal Investigator (PI) – CSR funding from Unique Biotech, Hyderabad of 10 Lacs INR on “To dissect the Immunomodulatory potential of Probiotics in ameliorating acute respiratory distress syndrome (ARDS)”, 2022-2024.


9. Principal Investigator (PI) – AIIMS-University College London Collaborative Research Grant of 10 Lacs INR on “To investigate the therapeutic potential of extracellular vesicles (EV) released by human induced pluripotent stem cell (hiPSC)-derived mesenchymal stem cells (iMSCs) to counteract oestrogen deficiency induced bone deterioration”, 2022-2023.


10. Principal Investigator (PI) – AIIMS-Interdisciplinary Research Grant of 20 Lacs INR on “A comparative study to evaluate the effect of first line therapies in Osteoporotic patients”, 2023-2025.


11. Principal Investigator (PI) – AIIMS-Intra Mural Research Grant of 10 Lacs INR on “To establish the role of Th9 cells in the pathophysiology of Osteoporosis”, 2022-2024.


12. Principal Investigator (PI) – AIIMS-Interdisciplinary Research Grant of 20 Lacs INR on “To investigate the regulatory potential of Estrogen in modulating differentiation and function of regulatory B cells: Implications in bone remodeling”, 2021-2023.


13. Principal Investigator (PI) – AIIMS-Interdisciplinary COVID-19 Research Grant of 10 Lacs INR on “To investigate the long-term impact of COVID-19 on bone health”, 2021-2022.


14. Principal Investigator (PI) – AIIMS-Intra Mural Research Grant of 10 Lacs INR on “To establish the role of regulatory B cells (Bregs) in post-menopausal Osteoporosis”, 2020-2022.


15. Principal Investigator (PI) - AIIMS-IIT-Delhi Inter Institutional Collaborative Research Grant of 20 Lacs INR on “Development of novel mushroom based synbiotic food supplement for management of Osteoporosis”,2019-2021.


16. Principal Investigator (PI) - AIIMS-Intra Mural Research Grant of 10 Lacs INR on “To Dissect the role of Treg-Th17 cells in Lactobacillus rhamnosus mediated inhibition of Bone loss in ovx mice”, 2018-2020.


17. Principal Investigator (PI) - University Grant Commission (UGC)-Start Up Grant (06 Lacs INR) on Effect of regulating “mammalian Target of Rapamycin” (mTOR) activity on RANKL induced Osteoclastogenesis, 2014-2016.